Clinical Trials Browser

OTHER × Drug-Related Side Effects and Adverse Reactions × Gefitinib × Clear all

NCT01965275 2017-05-08

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Phase 2 Unknown

Drug-Related Side Effects and Adverse Reactions